Updates in the Systemic Therapy Options for Clear Cell and Non–Clear Cell Renal Cell Carcinoma

At the NCCN 2023 Annual Conference, experts reviewed clinical data on established therapies for patients with metastatic renal cell carcinoma and discussed strategies to effectively manage both clear non–clear tumor histologies in setting of advanced stages. Depicted through 3 separate case studies, they strategized selection optimal first-line subsequent-line based individual study characteristics each.